Result summary of intravitreal bevacizumab (IVB), panretinal photocoagulation (PRP), pars plana vitrectomy (PPV) or observation performed on patients with vitreous haemorrhage (VH) in a real-life setting
| IVB | PRP | PPV | Observation | |
| No VHs | 224 | 22 | 43 | 47 |
| BCVA (logMAR*) | ||||
| Baseline | 1.15±0.70 | 0.55±0.57 | 0.39±0.43 | 0.24±0.33 |
| After | 0.42±0.42 | 0.19±0.21 | 0.75±0.62 | 0.26±0.34 |
| VH duration (days*) | 57±46 | 76±54 | 103±84 | 81±42 |
| IOP (mm Hg*) | ||||
| Baseline | 16.7±4.9 | 17.2±3.3 | 16.7±9.0 | 17.0±5.9 |
| After | 16.3±4.5 | 15.7±3.7 | 14.5±4.3 | 16.4±4.1 |
*Mean±SD.
BCVA, best corrected visual acuity; IOP, intraocular pressure; logMAR, logarithm of the minimum angle of resolution.